Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 21, 2020

SELL
$55.75 - $92.75 $246,972 - $410,882
-4,430 Closed
0 $0
Q1 2020

Apr 08, 2020

BUY
$37.9 - $104.44 $41,690 - $114,884
1,100 Added 33.03%
4,430 $257,000
Q4 2019

Jan 22, 2020

BUY
$77.66 - $99.74 $62,516 - $80,290
805 Added 31.88%
3,330 $308,000
Q3 2019

Oct 30, 2019

BUY
$90.37 - $122.49 $228,184 - $309,287
2,525 New
2,525 $228,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Harbour Capital Advisors, LLC Portfolio

Follow Harbour Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.